DARE: dara for R/R myeloma with renal impairment

Dara plus dex in R/R myeloma patients with renal impairmentПодробнее

MYELOMA UNIVERSITY | Learn about renal (kidney) impairment in patients with multiple myeloma.Подробнее

Ide-cel therapy for multiple myeloma with renal impairmentПодробнее

The impact of renal impairment on clinical outcomes with mezigdomide plus dex in R/R myelomaПодробнее

Managing and treating renal impairment in multiple myelomaПодробнее

Idecabtagene vicleucel for R/R multiple myeloma with renal impairmentПодробнее

Causes & management of renal impairment in patients with multiple myelomaПодробнее

Daratumumab and dexamethasone in the treatment of patients with myeloma and severe renal impairmentПодробнее

The impact of renal impairment on the MM treatment strategyПодробнее

Denosumab in multiple myeloma patients with renal insufficiencyПодробнее

Is dara being used in the frontline setting for myeloma patients?Подробнее

Improving the inclusion of patients with multiple myeloma with renal impairment in clinical trialsПодробнее

GMMG-DANTE: DVd in patients with multiple myeloma and renal impairmentПодробнее

DARA + pom-dex for R/R multiple myelomaПодробнее

How is myeloma kidney disease monitored? #myelomaПодробнее

GRIFFIN: follow-up after DARA + RVd for multiple myelomaПодробнее

Can belantamab mafodotin be used in patients with renal impairment?Подробнее

Managing renal failure in patients with multiple myelomaПодробнее

Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairmentПодробнее